Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone vs Metformin in Insulin Resistant PCOS
NCT07472179Completed
- Start
- Aug 2024
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of pioglitazone in polycystic ovary syndrome (PCOS) (2 arms). Primary endpoints: Biochemical parameters of insulin resistant PCOS at 3 months, Clinical parameters at 3 months and 1 more. Started Aug 2024; status: completed.
02
Drugs
pioglitazone
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT07472179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07472179.